VIR BIOTECHNOLOGY, INC. (VIR): Price and Financial Metrics
Today's Latest Price: $37.27 USD
Oct 22 4:00pm Add VIR to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
VIR Price/Volume Stats
VIR BIOTECHNOLOGY, INC. (VIR) Company Bio
Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA.
VIR Latest News Stream
All News Types
Loading, please wait...
Latest VIR News From Around the Web
Below are the latest news stories about Vir Biotechnology Inc that investors may wish to consider to help them evaluate VIR as an investment opportunity.
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IMMU, ORCL, VIR, UAL, and TSLA. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Janet Napolitano to its board…
By Matt Grossman Vir Biotechnology Inc. and GlaxoSmithKline Plc have dosed the first patient in a Phase 2/3 study of the use of a…
Vir Biotechnology (VIR): Q2 GAAP EPS of -$0.27 beats by $0.35.Revenue of $66.99M (+3167.8% Y/Y) beats by $63.09M.License granted to GSK under the collaboration agreement of $43.3M and $22.7M from Brii Biosciences.Press Release...
Read More 'VIR' Stories Here
VIR Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.6522 seconds.